PCNI8 A COST COMPARISON OF GEMZAR PLUS CISPLATIN WITH OTHER NOVEL AGENTS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN ITALY
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65752-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65752-X/fulltext
Title :
PCNI8 A COST COMPARISON OF GEMZAR PLUS CISPLATIN WITH OTHER NOVEL AGENTS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65752-X&doi=10.1016/S1098-3015(10)65752-X
First page :
Section Title :
Open access? :
No
Section Order :
117